IDiyas

For the Inventor, By the Inventor

Grenzach-Wyhlen, Germany

Matthias Koerner

USPTO Granted Patents = 30 

 

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Antdorf, DE (2006 - 2009)
  • Grenzach-Wyhlen, DE (2011 - 2022)
  • Basel, CH (2022)

Company Filing History:

goldMedal30 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):
1. 11358962 - 2-hetaryl imidazol[1,2-a]pyridine derivatives (2022-06-14),
2. 11306093 - Process for preparation of 2-(6-nitropyridin-3-yl)-9H-dipyrido[2,3-b;3',4′-d]pyrrole (2022-04-19),
3. 11058781 - Diazacarbazole derivatives as tau-PET-ligands (2021-07-13),
4. 10975073 - Imaging methods using 2-hetaryl imidazol[1,2-a]pyridine derivatives (2021-04-13),
5. 10138234 - 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives (2018-11-27),
6. 10004817 - Diazacarbazole derivatives as tau-PET-ligands (2018-06-26),
7. 9957266 - Imidazo[1,2-a]pyridin-7-amine (2018-05-01),
8. 9890124 - Benzazepine sulfonamide compounds (2018-02-13),
9. 9801961 - 2-phenylimidazo[1,2-a]pyrimidines as imaging agents (2017-10-31),
10. 9540384 - Pyrrolidino heterocycles (2017-01-10),
11. 9346763 - Process for the preparation of pyrazole carboxylic acid derivatives (2016-05-24),
12. 9227970 - Triazolopyridine compounds (2016-01-05),
13. 9187455 - Substituted pyridazines as PDE10A inhibitors (2015-11-17),
14. 8946427 - Triazolopyridine compounds (2015-02-03),
15. 8772510 - PDE10 modulators (2014-07-08),

Title: Matthias Koerner - Innovator in Molecular Imaging Tools

Introduction

Matthias Koerner is a prolific inventor based in Grenzach-Wyhlen, Germany, known for his significant contributions to the field of molecular imaging. With an impressive portfolio of 30 patents, he has made remarkable strides in developing innovative small molecule imaging tools.

Latest Patents

Among his recent patents, two noteworthy inventions stand out. The first patent focuses on 2-hetaryl imidazol[1,2-a]pyridine derivatives, which relate specifically to small molecule imaging tools. This invention includes compounds of formula II and pharmaceutically acceptable acid addition salts, with variations in R-R as defined in the specifications. The second patent describes a process for the preparation of 2-(6-nitropyridin-3-yl)-9H-dipyrido[2,3-b;3',4ʹ-d]pyrrole. The process involves coupling a specific compound with a suitable boronic acid under controlled conditions, along with isolation steps to yield the desired product as an acid addition salt.

Career Highlights

Matthias Koerner has established his career at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work primarily focuses on innovations that enhance imaging technologies, making significant contributions to research and development in healthcare.

Collaborations

Throughout his career, Koerner has collaborated with talented coworkers, including Luca Claudio Gobbi and Alexander Flohr. These collaborative efforts have helped to push the boundaries of research and development in molecular imaging, driving the advancement of medical applications.

Conclusion

Matthias Koerner exemplifies the spirit of innovation in the field of molecular imaging. With his extensive patent portfolio and commitment to research, he continues to influence the development of new technologies that pave the way for breakthroughs in healthcare and imaging sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…